Analysis of gene-environment interaction in coronary heart disease: Fibrinogen polymorphisms as an example

Italian Heart Journal

Volumn 3, Issue 1, 2002, Pages 18-23

  Vischetti, Michela ^a   Zito, Francesco ^a   Donati, Maria Benedetta ^a   Iacoviello, Licia ^a  

^a Dipt Med Farmacol Vascolare   (Italy)

Author keywords

Fibrinogen; Gender; Gene environment interaction; Infections; Physical activity; Polymorphisms

Indexed keywords

FIBRINOGEN;

ARTICLE; BETA CHAIN; CARDIOVASCULAR RISK; CIGARETTE SMOKING; CONTROLLED STUDY; DRUG USE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGY; FEMALE; FIBRINOGEN BLOOD LEVEL; GENDER; GENE CONTROL; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HELICOBACTER INFECTION; HUMAN; ISCHEMIC HEART DISEASE; MALE; MOLECULAR GENETICS; MULTIFACTORIAL GENETIC DISORDER; PHENOTYPE; PHYSICAL ACTIVITY;

CORONARY ARTERIOSCLEROSIS; ENVIRONMENTAL EXPOSURE; EXERCISE; FEMALE; FIBRINOGEN; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MOLECULAR BIOLOGY; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 0036208472     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (65)

1. Haemostatic function and ischaemic heart disease: Principal results of the Northwick Park Heart Study
2. Fibrinogen as a risk factor for stroke and myocardial infarction
3. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men
4. The effects of physiological levels of fibrinogen on platelet aggregation
5. The role of fibrinogen in platelet aggregation
6. Blood rheology and thrombosis
7. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study
8. Fibrinogen as a cardiovascular risk factor: A meta-analysis and review of the literature
9. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies
10. Haemostatic variables and the outcome of myocardial infarction
11. Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: The Scottish Heart Health Study
12. Association of haemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis
13. The genes coding for Aα, Bβ-, and γ-chains of fibrinogen map to 4q2
14. Evolution and organization of the fibrinogen locus on chromosome 4: Gene duplication accompanied by transposition and inversion
15. Interaction of a liver-specific nuclear factor with the fibrinogen and alpha 1-antitrypsin promoters
16. The human β-fibrinogen promoter contains a hepatocyte nuclear factor 1-dependent interleukin-6 responsive element
17. Fibrinogen precursors. Order of assembly of fibrinogen chains
18. Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations
19. Fibrinogen genotype and risk of peripheral atherosclerosis
20. Plasma fibrinogen levels and fibrinogen genotype in non-insulin dependent diabetics
21. +1689 (AvaII), and BclI (β-fibrinogen) and TaqI (α-fibrinogen), detection by PCR
22. β-fibrinogen gene polymorphisms are associated with plasma fibrinogen and coronary artery disease in patients with myocardial infarction. The ECTIM Study. Etude Cas-Temoin sur l'Infarctus du Myocarde
23. Variation in the promoter region of the β-fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers
24. Genetic variation at fibrinogen loci and plasma fibrinogen levels
25. Polymorphisms of the beta fibrinogen gene and plasma fibrinogen concentration in Caucasian and Japanese population samples
26. Gender-related association between β-fibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greenland Inuit
27. Genetic variation at the β-fibrinogen locus in relation to plasma fibrinogen concentrations and risk of myocardial infarction. The ECTIM Study
28. BclI polymorphism in the gene of the fibrinogen β-chain is associated with the risk of familial myocardial infarction by increasing plasma fibrinogen levels: A case-control study in a sample of GISSI-2 patients
29. Helicobacter pylori infection and the risk of myocardial infarction: Role of fibrinogen and its genetic control
30. Fibrinogen polymorphisms are not associated with the risk of myocardial infarction
31. Raised plasma fibrinogen concentrations in subjects attending a metabolic ward - Relation to family history and vascular risk factors
32. Beta-fibrinogen gene -455 G/A polymorphism and fibrinogen levels. Risk factors for coronary artery disease in subjects with NIDDM
33. Variation in plasma fibrinogen over one year: Relationships with genetic polymorphisms and non-genetic factors
34. The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden
35. European Atherosclerosis Research Study: Genotype at the fibrinogen locus (G-455-A β-gene) is associated with differences in plasma fibrinogen levels in young men and women from different regions in Europe. Evidence gender-genotype-environment interaction
36. A common mutation in the β-fibrinogen promoter is an independent predictor of plasma fibrinogen, but not of ischaemic heart disease. A study of 9127 individuals based on the Copenhagen City Heart Study
37. Positive association of the beta fibrinogen variation to basal fibrinogen levels and to the increase in fibrinogen concentration during acute phase reaction but not to coronary artery disease and myocardial infarction
38. Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease
39. Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms - The Leiden Thrombophilia Study (LETS)
40. The acute rise in serum fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the beta-fibrinogen gene
41. The effect of genotype and infant weight on adult plasma levels of fibrinogen, factor VII and LDL cholesterol are additive
42. Impact of the polymorphisms in the alpha- and beta-fibrinogen gene on plasma fibrinogen concentrations of coronary heart disease patients
43. Fibrinogen plasma levels in an apparently healthy general population - Relation to environmental and genetic determinants
44. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study
45. Two common, functional polymorphisms in the promoter region of the β-fibrinogen gene contribute to regulation of plasma fibrinogen concentration
46. Beta-fibrinogen gene G/A-455 polymorphism in relation to fibrinogen concentrations and ischaemic heart disease in Chinese patients with type II diabetes
47. The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischemic stroke involving large-vessel disease
48. The -455 G/A polymorphism of the β-fibrinogen gene is associated with the progression of coronary atherosclerosis in symptomatic men: Proposed role for an acute phase reaction pattern of fibrinogen
49. Regulation of acute phase gene expression by inflammatory mediators
50. Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population - II. Baseline data on the relation to blood pressure, blood glucose, uric acid, and lipid fractions
51. Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease
52. Population-based distributions of haemostatic variables
53. Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations
54. Haemostatic variables associated with diabetes and its complications
55. Association of genetic variation at the β-fibrinogen locus and plasma fibrinogen levels: Interaction between allele frequency of the G/A -455 polymorphism, age, smoking
56. The RsaI polymorphism in the alpha-fibrinogen gene and response of plasma fibrinogen to physical training - A controlled randomised clinical trial in men
57. Physical activity, fitness, and plasma fibrinogen with reference to fibrinogen genotypes
58. Physical activity, fibrinogen plasma level and gene polymorphisms in postmenopausal women
59. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
60. Relation of Helicobacter pylori infection and coronary heart disease
61. Association of Helicobacter pylori infection with coronary heart disease. Study shows association between H pylori infection and hypertension
62. Helicobacter pylori seropositivity in myocardial infarction
63. Chronic infections and coronary heart disease: Is there a link?
64. Helicobacter pylori infection: Relation with cardiovascular risk factors, ischaemic heart disease, and social class
65. Fibrinogen: A link between chronic infection and coronary heart disease